Recent patents on anti-cancer drug discovery
CAD is Associated with Cancer Prognosis and Promotes Enzalutamide Resistance in Prostate Cancer.
Bing-Xue Ma, Yi-You Mao, Ze-Fan Zhang, Xian-Zi Zeng, Xiao Xie, Hua Zhao, Qin Li, Ying-Hao Wen, Mao-Ping Cai, Tao Xie, Yu-Zhong Yu, Shan-Chao Zhao, Yang-Zi Ren
Published: 202510.2174/0115748928412596251011092220
Abstract
INTRODUCTION: Preliminary investigations into the feasibility of Carbamoyl-phosphate synthetase 2, Aspartate transcarbamoylase, and Dihydroorotase (CAD)-targeted therapies have been conducted in a limited range of cancer types in pre-clinical studies…
Preview only. Read the full abstract at the source